Smaqy The product of the nm23 gene has been proposed as a candidate tumour metastasis suppressor proten. A 
human term placenta and a highly metastatic human choriocarcinoma cell line, JAR. nm23 expression was signifntly higher in JAR than in normal placenta, indicating that nm23 does not appear to have an anti-metastabc function in this cell lne. Sevral cytokines -interkin 2 (IL-2), tumour necrosis factor alpha (TNF-a) and interferon gamma (IFN-y) -and prostaglaidin E2 (PGE2) known to modulate tumour growth and metastasis were examined to determine whether they regulate nm23 exresson in JAR in vitro. The B16FIO melanoma cell line was used as control. No effect was found in the JAR cell he, whereas TNF.41, IFN-y and PGE2 down-regulated nm23 expression in the B16FIO cell line. We conclude that high nm23 expression may be assoated with cell proliferation and not correlate with its anti-invasive activity in the early stage of gestation and in the JAR cell lne. The constant high n23 levl in the fetal tissue throughout the gestation sugests that wn23 may play an important role in embryogeness. Given the exstence of a strong association between reduced nm23 expsson and acquisition of metastatic behaviour in melanoma, the observation of down-regulation of nm23 expression by cytokines in B16F1O melanoma cels but not in JAR cells supports the notion that tissue-specific factors may be involved in the dissciation of nm23 expression from its antimetastaic activity in JAR cells.
It has recently been suggested that the protein product of nm23 gene plays an important role in tumour metastasis suppresson (Rosengrd et al., 1989; Steeg et al., 1989) . The nm23 protein has substantial homology with the protein encoded by a Drosophila abnormal wing discs (awd) developmental gene and nucleoside diphosphate (NDP) kinase, which catalyses the phosphorylation of nuleoside diphosphate into nucleoside triphosphates (Biggs et al., 1990; Kimura et al., 1990; Wallet et al., 1990) . The abundance of nm23 expression has been reported to be inversely correlated with metastatic potential in several rodent metastasis model systems: murine k-1735 melanomas (Steeg et al., 1988a -, Leone et al., 1991 , N-nitrosomethylurea-induced rat mammary tumours (Steeg et al., 1988a) , mouse mammary tumour virus-induced tumours (Steeg et al., 1989 ) and ras ± adenovirus 2 Ela-co-transfected rat embryo fibroblasts (Steeg et al., 1988b) . The expression of human nm23 gene has also been found to be lower in human breast cancer speimens with high metastatic potential than in those with low metastatic potential (Bevilacqua et al., 1989; Banmes et al., 1991; Hennessy et al., 1991; Hirayama et al., 1991) . Such a correlation, however, has not been observed in some other human tumours, such as colon cancer (Haut et al., 1991) , neuroblatoma (Hailat et al., 1991) , some solid tumours including breast carcinoma (Lacombe et al., 1991) and thyroid carcinomas (Zou et al., 1993) . The expression of the gene is increased equally in both high-and low-metastatic colon cancers. In neuroblastoma and thyroid carcinoma nm23 expression is positively associated with advanced disease stage (Hailat et al., 1991; Zou et al., 1993) .
Trophoblast cells of the blastocyst and of the normal first-trimester placenta share some phenotypic similarities with malignant cells, e.g. rapid proliferation and ability to invade neghbouring tissues, including basement membrane, during the process of implantation and placental development, but do not have the ability for unlimited growth or metastasis, as few trophoblast cells can be identified in the decidua, and trophoblasts rarely penetrate the maternal blood vessels (Yagel et al., 1988) . In the present study, we examined the abundance of nm23 mRNA from various fetal-maternal interface tissues (uterus, decidua, placenta and embryo) during early (day 8), mid (day 14) Both cell lines were maintained in RPMI-1640 medium supplemented with 10% fetal calf serum (FCS), penicillin (l00 U m'l"), streptomycin (l00 ;Lg ml ') and fungizone (25jtgml-1) at 37'C in a humidified atmosphere containing 5% carbon dioxide.
RNA extraction and Northern hybridisation Total RNA was extracted by the guanidinium thiocyanatephenol-chloroform method (Chomczynski & Sacchi, 1987) .
A 20 ILg aliquot of total RNA was fractionated on 1% agarose gel containing 2.2 M formaldehyde and blotted onto nylon membranes (Hybond-N, Amersham) by capillary transfer. The accuracy of RNA loading was monitored by ethidium bromide staining and/or by hybridisation to an oligoprobe for 18S ribosomal RNA as previously described (Shi et al., 1991 (Figure 2 ). As shown in Figures 1 and 2 , nm23 was expressed in all the tissues examined as early as day 8. The expression levels were, however, variable among different tissues and development stages. In the early stage (day 8), nm23 mRNA levels were high and similar among tissues from the uterus, decidua, placenta and embryo. In the mid stage (day 14), the mRNA levels were reduced significantly in the uterus, decidua and placenta, but not in the embryo. In the late stage, nm23 mRNA levels were further reduced to the extent that nm23 mRNA could not be seen in the decidua, was barely seen in the uterus and was weakly present in the placenta. The mRNA level in the embryo at this stage, however, was still high and comparable to the early stage. performed in order to rule out the possibility of enzymatic errors in reverse transcription and, more commonly, in PCR amplification with Taq polymerase. A total of five clones (three from the first RT-PCR and two from the second RT-PCR) were sequenced. The first RT-PCR examined showed a change in codon 38 from CTG (leucine) to CIT (leucine) in one of the three clones sequenced. The second RT-PCR examined was completely identical with the published cDNA sequences (Rosengard et al., 1989) , indicating that the change is an RT-PCR artifact (data not shown). Thus, no mutation was found in the coding region of the nm23-Hl gene.
Regulation of nm23 expression by cytokines and prostaglandin E2 It has been shown that several cytokines can modulate nm23 antimetastatic activity in melanoma cells in vivo (Leone et al., 1991) . It is not clear whether this is a direct or indirect effect on nm23. It is also not clear whether this modulation can be generalised to different types of tumours. In this regard, we analysed nm23 mRNA levels in JAR choriocarcinoma cells, which were cultured either alone or with IL-2, TNF-a, IFN--, IL-2 plus IFN-y or PGE2 for 16 h. PGE2 (not cytokine) was included in the experiment because previous reports have shown that PGE2 can promote tumour metastasis (Garaci et al., 1987; Fulton et al., 1991; Young et al., 1991) . B16FIO melanoma cells were also included in the experiments as a control. As shown in Figure 4a , IL-2 has no effect on nm23 expression in B16FIO melanoma cells. A 4-fold reduction of nm23 transcripts was, however, observed when the cells were cultured with TNF-4 or PGE2. A 2-fold reduction was noted with either IFN-y alone or IFN-y plus IL-2 treatment. Surprisingly, the cytokines and PGE2 have no effect on nm23 expression in JAR cells (Figure 4b ).
The data presented herein demonstrate differential nm23 expression among fetal-maternal interface tissues during gestation, the highest level being found in early stage of gestation. The high level of nm23 expression in the fetal-matemal interface tissues (uterus, decidua, placeta) may be involved in the protection of maternal tissues from highly invasive trophoblast cells during the early stage of gestation. The progressive reduction in nm23 expression in uterus, decidua and placenta coincides with the progression of gestation and the reduction of invasiveness of trophoblast cells. This suggests that the reduced nm23 mRNA may be associated with ageing of these tissues and that the need for nm23 antimetastatic activity is reduced in late stage of gestation. However, as evidenced by the high level of nm23 mRNA in the human choriocarcinoma cell line JAR, high nm23 expression appears to be associated with rapid cell proliferation instead of its antimetastatic activity, thus contradicting the above hypothesis.
Tumours derived from JAR choriocarnoma cells are histopathologically similar to what has been described for spontaneous chonrocarcnomas of the uterus in women, in which larg multinuceated cells (syncytiotrophoblasts) are common.
The invasiveness of JAR cells is similar to or even higher than that of a highly metastatic mure melanoma line B16FIO (Yagel et al., 1988) , in which we have recently found that increased nm23 expression in B16FIO cells is associated with reduced pulmonary metastases (Parhar et al., submitted Association of high nm23 expression with rapid cell proliferation has been inicated in certain tumours such as neuroblastoma (Hailat et al., 1991) , colon cancer (Haut et al., 1991) and thyroid tumour (Zou et al., 1993) , and supported by a study showing that nm23-HI expression is related to cell proliferation (Keim et al., 1992) . It is known that the nm23 gene product has NDP kinase activity which provides intracllular pools of nucleside triphosphates (excling ATP) required for nucleic acid synthesis (Liotta & Steeg, 1990; Gilles et al., 1991) . In many systems, NDP kinases have been found to be associated with GTP-binding proteins, incuding elongation factor (Walton & Gill, 1975; Ohtsui & Yokoyama, 1987) , microtubules (Nickerson & Wells, 1984) and p21 (Ohtsuki et al., 1986) or Gsm (Kimura & Shimada, 1988;  Otero, 1990) , s g that they are involved in proceses such as protein synthesis, tubulin polymerisation in the mitotc spindle and cytoskeleton and signal transduction by supplying GTP to GTP-binding proteins. A recent study has shown that the protein encoded by nm23-H2, one of two cosely related human n23 genes, may be a trnciption factor that turns on the cllular myc gene, which is known to have ancer causg potential (Postel et al., 1993 (Parhar et al., submitted) . In vivo treatment with TNF-4 or IFN-y or PGE2 in experimental mice injected with B16F1O cells increased the pulmonary metastases and reduced the overall survival period as compared with those without any pretreatment (Parhar et al., submitted) . The effect of cytoknes on nm23 expression was, however, not observed in JAR cells in this study. Given that a strong association was found between reduced nm23 expression and acquistion of metastatic behaviour in melanoma (Steeg et al., 1988a; Leone et al., 1991) and that no such an association exists in malignant trophoblast cells, the observation of down-regulation of nm23 expression by some cytokines in B16F1O cells but not in JAR cells supports the notion that tissue-specific factors may be involved in the disociation of nm23 expression from its antimetastatic activity in JAR cells. It may also suggest that nm23 is not directly involved in the tumour metastasis suppresson, but rather is an intermediate product in the tumour meta suppression process, and its expression and function could be modulated by tissue-specific factors.
The human nm23-H2 gene has been discovered. It encodes a protein with a predicted M, = 17,000 and is 88% identical to the nm23-HI protein sequence (Stahl et al., 1991) . The nm23-HI probe we used does not efficiently distinguish between the two nm23 mRNAs. Norhern blot hybridisation of nm23-H2-specific probe to breast tumours and cell nes shows that nm23-H2 expression was also reduced in high metastatic potential tumour cells but to a lesser extent than nm23-HI (Stahl et al., 1991) 
